Clinical trial · Interventional
National Lung Screening Trial (NLST) Screening
National Lung Screening Trial A Randomized Trial Comparing Low-dose Helical CT With Chest Xray for Lung Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Effective screening tests should help doctors detect lung cancer early and plan curative treatment. It is not yet known whether low-dose helical computed tomography (LDCT) screening is more effective than chest radiography (CXR) screening in reducing death from lung cancer. PURPOSE: Randomized clinical trial to compare the effectiveness of LDCT scan with that of CXR in screening individuals who are at high risk for developing lung cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| chest radiography | Device | — | UNRESOLVED |
| low-dose helical computed tomography | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Low-Dose CT
- interventionNames
- Device: low-dose helical computed tomography
- type
- EXPERIMENTAL
- label
- Chest X-ray
- interventionNames
- Device: chest radiography
Primary outcomes (1)
- measure
- Lung Cancer Deaths
- timeFrame
- All events through December 31, 2009; median follow-up 6.5 years.
- description
- Lung cancer deaths confirmed in participants by Endpoint Verification if available, otherwise by death certificate.
Secondary outcomes (6)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 55 Years
- Maximum age
- 74 Years
Show eligibility criteria text
Inclusion Criteria: * Age 55-74 years (pack-years = packs per day \* years smoked) * 30 or more pack-years of cigarette smoking history * Former smokers: quit smoking within the previous 15 years * Ability to lie on the back with arms raised over the head * Signed informed consent form Exclusion Criteria: * Metallic implants or devices in the chest or back, such as pacemakers or Harrington fixation rods * Treatment for, or evidence of, any cancer other than nonmelanoma skin cancer or carcinoma in situ (with the exception of transitional cell carcinoma in situ or bladder carcinoma in situ) in the 5 years prior to eligibility assessment * History of lung cancer * History of removal of any portion of the lung, excluding needle biopsy * Requirement for home oxygen supplementation * Participation in another cancer screening trial * Participation in a cancer prevention study, other than a smoking cessation study * Unexplained weight loss of more than 15 pounds in the 12 months prior to eligibility assessment * Recent hemoptysis * Pneumonia or acute respiratory infection treated with antibiotics in the 12 weeks prior to eligibility assessment * Chest CT examination in the 18 months prior to eligibility assessment
References
Publications (1)
- Source
- PubMed (NLM)
- Dataset
- PubMed E-utilities
- Retrieved
- Sep 9, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
Yaguang Fan, Ying Wang, Xuebing Li et al. · Cancer Epidemiol · Oct 1, 2026 · PMID 42580153 pubmed
- BACKGROUNDNational Lung Screening Trial Research Team; Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, Galen B, Gareen IF, Gatsonis C, Goldin J, Gohagan JK, Hillman B, Jaffe C, Kramer BS, Lynch D, Marcus PM, Schnall M, Sullivan DC, Sullivan D, Zylak CJ. The National Lung Screening Trial: overview and study design. Radiology. 2011 Jan;258(1):243-53. doi: 10.1148/radiol.10091808. Epub 2010 Nov 2. PMID 21045183
- BACKGROUNDCody DD, Kim HJ, Cagnon CH, Larke FJ, McNitt-Gray MM, Kruger RL, Flynn MJ, Seibert JA, Judy PF, Wu X. Normalized CT dose index of the CT scanners used in the National Lung Screening Trial. AJR Am J Roentgenol. 2010 Jun;194(6):1539-46. doi: 10.2214/AJR.09.3268. PMID 20489094